-
1
-
-
0025972793
-
Noninvasive measures of oxidative stress status in humans
-
W.A. Pryor S.S. Godber Noninvasive measures of oxidative stress status in humans Free Radic. Biol. Med. 10 1991 177 184
-
(1991)
Free Radic. Biol. Med.
, vol.10
, pp. 177-184
-
-
Pryor, W.A.1
Godber, S.S.2
-
3
-
-
85120117163
-
-
A.C. Brown The last hero. Wild Bill Donovan 1982 Times Books New York
-
(1982)
-
-
Brown, A.C.1
-
4
-
-
0027603748
-
Measurement of oxidative stress status in humans
-
W.A. Pryor Measurement of oxidative stress status in humans Cancer Epidemiol. Biomarkers Prev. 2 1993 289 292
-
(1993)
Cancer Epidemiol. Biomarkers Prev.
, vol.2
, pp. 289-292
-
-
Pryor, W.A.1
-
5
-
-
0016589386
-
A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation
-
W.A. Pryor J.P. Stanley A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation J. Org. Chem. 40 1975 3615 3617
-
(1975)
J. Org. Chem.
, vol.40
, pp. 3615-3617
-
-
Pryor, W.A.1
Stanley, J.P.2
-
7
-
-
0025058849
-
Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids
-
J.D. Morrow T.M. Harris L.J. Roberts II Noncyclooxygenase oxidative formation of a series of novel prostaglandins analytical ramifications for measurement of eicosanoids Anal. Biochem. 184 1990 1 10
-
(1990)
Anal. Biochem.
, vol.184
, pp. 1-10
-
-
Morrow, J.D.1
Harris, T.M.2
Roberts, L.J.3
-
8
-
-
0028276746
-
Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical catalyzed mechanism
-
2-isoprostanes produced by non-cyclooxygenase free radical catalyzed mechanism Methods Enzymol. 233 1994 163 174
-
(1994)
Methods Enzymol.
, vol.233
, pp. 163-174
-
-
Morrow, J.D.1
Roberts, L.J.2
-
10
-
-
0028216849
-
Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro
-
2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro J. Clin. Invest. 93 1994 998 1004
-
(1994)
J. Clin. Invest.
, vol.93
, pp. 998-1004
-
-
Lynch, S.M.1
Morrow, J.D.2
Roberts, L.J.3
Frei, B.4
-
11
-
-
0030065476
-
The isoprostanes. Current knowledge and directions for future research
-
J.D. Morrow L.J. Roberts II The isoprostanes. Current knowledge and directions for future research Biochem. Pharmacol. 51 1996 1 9
-
(1996)
Biochem. Pharmacol.
, vol.51
, pp. 1-9
-
-
Morrow, J.D.1
Roberts, L.J.2
-
12
-
-
0032401897
-
Radically novel prostaglandins in animals and plants: the isoprostanes
-
M.J. Mueller Radically novel prostaglandins in animals and plants the isoprostanes Chem. Biol. 5 1998 R323 R333
-
(1998)
Chem. Biol.
, vol.5
, pp. R323-R333
-
-
Mueller, M.J.1
-
13
-
-
0032905527
-
Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis
-
P. Holvoet Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis Expert Opin. Invest. Drugs 8 1999 527 544
-
(1999)
Expert Opin. Invest. Drugs
, vol.8
, pp. 527-544
-
-
Holvoet, P.1
-
14
-
-
85120098167
-
-
Pryor, W. A. Vitamin E and heart disease: biochemistry to human trials. Free Radic. Biol. Med . in press; 2000.
-
-
-
|